Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.34−0.23 (-4.04%)
Close on Nov 18, 2026Market cap $463.35MP/E –Yield –
Valneva net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2021 it was -€61.39M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -€61.39M | – |
| FY2020 | Dec 31, 2020 | -€55.12M | – |
| FY2019 | Dec 31, 2019 | -€811.00K | – |
See a number that looks wrong?